This site is intended for U.S. healthcare professionals.
*Based on demonstrated effectiveness against 14 diverse strains representative of prevalent MenB strains.1
ONLY TRUMENBA offers confirmed protection against diverse MenB strains* with a dosing schedule of 0 and 6 months that aligns with adolescents' typical return to the office.1-4†
ONLY TRUMENBA covers both subfamilies of fHbp, A & B, that have been found on 99% of MenB disease-causing strains, as well as strains that have caused MenB outbreaks at US colleges.1,7-9
fHbp=factor H binding protein.
MenB vaccination is part of the CDC
16-year-old vaccination platform.5,10†
CDC=Centers for Disease Control and Prevention.
Learn more about TRU NextDose, an adherence program created to ensure your patients complete the TRUMENBA vaccination series.
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.
You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.